Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

COVID-19: TCTMD’s Dispatch for October Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 3

October 18, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

Compensation in 2020 Survived COVID-19, CV Professionals Say

News Daily News

Compensation in 2020 Survived COVID-19, CV Professionals Say

September 10, 2021

COVID-19: TCTMD’s Daily Dispatch for June Week 2

News Daily News

COVID-19: TCTMD’s Daily Dispatch for June Week 2

June 07, 2021

COVID-19: TCTMD’s Daily Dispatch for June Week 1

News Daily News

COVID-19: TCTMD’s Daily Dispatch for June Week 1

June 01, 2021

COVID-19: TCTMD’s Daily Dispatch for May Week 3

News Daily News

COVID-19: TCTMD’s Daily Dispatch for May Week 3

May 17, 2021

COVID-19: TCTMD’s Daily Dispatch for May Week 1

News Daily News

COVID-19: TCTMD’s Daily Dispatch for May Week 1

May 02, 2021

Virtual Training Booms as COVID-19 Limits In-Person Proctoring, Observation

News Features

Virtual Training Booms as COVID-19 Limits In-Person Proctoring, Observation

Yael L. Maxwell

April 21, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.